GSK plc (FRA:GS71)

Germany flag Germany · Delayed Price · Currency is EUR
19.05
+0.18 (0.95%)
At close: Oct 21, 2025
0.95%
Market Cap76.33B
Revenue (ttm)36.90B
Net Income (ttm)3.99B
Shares Outn/a
EPS (ttm)0.96
PE Ratio19.11
Forward PE9.45
Dividend0.75 (4.00%)
Ex-Dividend DateAug 14, 2025
Volume298,790
Average Volume1,802
Open18.93
Previous Close18.87
Day's Range18.91 - 19.12
52-Week Range14.68 - 19.36
Betan/a
RSI63.00
Earnings DateOct 29, 2025

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It a... [Read more]

Industry Pharmaceutical Preparations
Founded 1715
Employees 68,629
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol GS71
Full Company Profile

Financial Performance

In 2024, GSK plc's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.

Financial numbers in GBP Financial Statements

News

There is no news available yet.